Published in Hepatitis Weekly, September 2nd, 2002
The podium presentation entitled, "Evaluation of the AERx System for the Pulmonary Delivery of Recombinant Human Interferon alfa-2b to Healthy Subjects," was presented at the 29th annual meeting of the Controlled Release Society in Seoul, Korea. Data showed that the AERx Pulmonary Drug Delivery System appears to be safe, convenient, and well tolerated for the noninvasive systemic delivery of interferon alfa-2b using the inhalation route in healthy volunteers.
Interferon alfa delivered by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.